Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / COMMON STOCK, PAR V ALUE $0.001 PER SHARE
-
Shares outstanding
-
74.9M
-
Number of holders
-
97
-
Total 13F shares, excl. options
-
17.1M
-
Shares change
-
-176K
-
Total reported value, excl. options
-
$74.2M
-
Value change
-
-$748K
-
Put/Call ratio
-
5.08
-
Number of buys
-
52
-
Number of sells
-
-29
-
Price
-
$4.33
Significant Holders of CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) as of Q2 2024
112 filings reported holding CRMD - CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE as of Q2 2024.
CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) has 97 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.1M shares
of 74.9M outstanding shares and own 22.86% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.55M shares), VANGUARD GROUP INC (2.9M shares), Elliott Investment Management L.P. (1.55M shares), NOMURA HOLDINGS INC (1.42M shares), GEODE CAPITAL MANAGEMENT, LLC (1.27M shares), STATE STREET CORP (1.22M shares), MILLENNIUM MANAGEMENT LLC (447K shares), NORTHERN TRUST CORP (446K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (368K shares), and MORGAN STANLEY (271K shares).
This table shows the top 97 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.